NCT05728671

Bioavailability Study to Compare Liquid vs Two Solid Formulations of IP2015

An Open-Label, Bioavailability Study to Compare Liquid vs Two Solid Formulations of IP2015 in Healthy Male Subjects

• Status: Unknown
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 12 (estimated)
• Sponsor: Initiator Pharma · Industry
• Sex: Male
• Age: 18 Years – 55 Years
• Healthy volunteers: Accepted

Summary

The study's primary objective is to determine the bioavailability of two solid formulations of IP2015 compared to a liquid formulation of IP2015 in healthy male subjects

Detailed description

It is planned to include 12 subjects. Each subject will take part in three treatment periods, in which they will receive a single dose of IP2015 liquid and then to different IP2015 solid formulations, respectively, in each treatment period. Overall, each subject will receive each treatment once only.

Conditions

• Bioavailability

Interventions

Type	Name	Description
DRUG	IP2015	Test drug

Timeline

• Start date: 2023-02-16
• Primary completion: 2023-05-16
• Completion: 2023-07-20
• First posted: 2023-02-15
• Last updated: 2023-02-15